Characteristic | Control (n = 13) | DMR (n = 12) | VEGF (n = 10) |
---|---|---|---|
Age* (y) | 64 ± 5 | 60 ± 8 | 63 ± 8 |
Sex (M/F) | 9/4 | 11/1 | 9/1 |
Hypercholesterolemia | 12 | 11 | 10 |
Hypertension | 3 | 7 | 4 |
Diabetes | 0 | 3 | 4 |
Smoking | 2 | 2 | 1 |
Previous MI* | 1.3 ± 0.54 | 1.8 ± 0.4 | 1.1 ± 0.5 |
Previous PCI* | 1.2 ± 1.9 | 1.8 ± 2.0 | 1.1 ± 1.6 |
Previous CABG* | 0.8 ± 0.6 | 1.1 ± 1.1 | 1.0 ± 0.8 |
1-Vessel disease | 2 | 2 | 0 |
2-Vessel disease | 6 | 6 | 3 |
3-Vessel disease | 5 | 4 | 7 |
Long-acting nitrates | 9 | 9 | 8 |
Calcium antagonists | 11 | 9 | 9 |
β-Blockers | 12 | 11 | 8 |
ACE Inhibitors | 6 | 3 | 3 |
Statins | 11 | 12 | 10 |
Diuretics | 3 | 4 | 5 |
Aspirin | 7 | 9 | 5 |
Coumarins | 6 | 3 | 4 |
↵* Values are mean ± SD.
MI = myocardial infarction; PCI = percutaneous coronary intervention; CABG = coronary artery bypass graft; ACE = angiotensin-converting enzyme.